Reading a Research Vial Label: Every Field and What It Commits the Supplier To

Read a research vial label as a short list of promises, not as a description of the contents. The useful fields all have defined meanings in published standards: the identity of the material, the batch it came from, the quantity in the container, the storage condition under which any dating claim holds, and the legal category it is sold in. Each of those can be checked — against the certificate of analysis, against the packing documents, against the goods that actually arrived. Everything else on the glass is decoration.

That is the whole skill: sorting the printed fields into ones with a defined meaning and ones without. "Lot 240118-B" is a defined field with a regulation behind it ^[2]. "High purity", "lab tested" and "store cool" are not fields at all — they commit nobody to anything. The ratio between the two is a faster read on a supplier's documentation discipline than any amount of website copy.

No US or Canadian regulation is titled "labelling of research peptides", and that is worth saying before going field by field. Three separate rule sets converge on the same small piece of glass, none of them written for this object: pharmaceutical labelling convention from ICH Q7 ^[1], workplace hazard communication from OSHA in the United States ^[5] and the Hazardous Products Regulations in Canada ^[6], and a research-use-only statement borrowed from the FDA's in vitro diagnostic rules ^[3]. Between them they explain nearly everything legible on a vial — and why two suppliers can both be labelling correctly and produce labels that look nothing alike.

What fields should be on a research vial label?

ICH Q7 is the closest thing to a field list, and it is short. Section 9.42 says labels on containers of intermediates or active substances should indicate the name or identifying code, the batch number of the product, and the storage conditions where that information is critical to assuring quality. Section 9.43 adds what appears once material leaves the manufacturer's own material management system: the manufacturer's name and address, the quantity of contents, and any special transport conditions or special legal requirements. The same section settles dating — an expiry date on the label and the certificate of analysis, a retest date on the label and/or the certificate ^[1].

• Material name or identifying code — the identity claim, which must match the certificate exactly ^[1].
• Batch or lot number — the traceability key; transcribe it character for character ^[2].
• Quantity of contents — the nominal fill claim, required once material leaves the manufacturer's system ^[1].
• Storage conditions — required where quality-critical, and the condition every dating claim depends on ^[1].
• Expiry or retest date — expiry belongs on both label and certificate; a retest date may sit on either ^[1].
• Manufacturer name and address — the party the other claims belong to ^[1].
• Special transport conditions and legal requirements, including any research-use-only statement ^[1][3].
• Hazard communication elements, where the material is classified as hazardous in the destination country ^[5][6].

Notice what is absent: purity, assay, water content, endotoxin, method. None of it belongs on a label, and its absence there is not a gap. The label is an identifier that travels with the container; the analytical record is a separate document with its own field-by-field structure that the batch number points at. A purity figure printed on glass is a number with no method, no chromatogram and no signature behind it.

Lot number vs batch number: is there a difference?

In conversation the two words are interchangeable. In US drug regulation they are not. 21 CFR 210.3 defines a batch as a specific quantity of a drug or other material intended to have uniform character and quality within specified limits, produced according to a single manufacturing order during the same cycle of manufacture. A lot is defined as a batch, or a specific identified portion of a batch, holding to the same uniformity — or, for material made by a continuous process, a specific identified amount produced in a unit of time or quantity ^[2].

So a lot may be a whole batch or a slice of one. Two containers bearing different lot numbers can share a batch and a single set of analytical results, which is why one certificate covering several lot numbers is a question rather than a red flag. The same regulation defines the identifier itself: a lot number, control number or batch number is any distinctive combination of letters, numbers or symbols from which the complete history of the manufacture, processing, packing, holding and distribution of that batch or lot can be determined ^[2]. That is the commitment hiding inside a nine-character string.

Practically: transcribe the identifier exactly as printed — leading zeros, separators, suffix letters — and record whether the label calls it a lot or a batch. Flattening both into whichever field your log happens to have is how a discrepancy between label and certificate becomes invisible six months later. Where a container carries both a batch number and a separate fill or packing number, record both; ICH Q7 anticipates that pairing when material is subdivided after release ^[1].

What the mass on the label actually claims

The quantity of contents is a specification statement about the intended fill, not a measurement of the container in your hand. ICH Q7 requires the quantity to appear once material leaves the manufacturer's control ^[1], but nothing in that requirement obliges anyone to publish the tolerance around it, and research-grade labels essentially never do. The printed figure commits the supplier to a target, and leaves two questions unanswered on the glass.

The sharper of the two is not a label question at all. Lyophilised peptide solids carry counter-ions, residual water and residual solvent, so the weighed mass in a vial and the mass of peptide within it are different numbers by construction. Which of the two a figure refers to is settled on the certificate — where net peptide content is stated apart from the gross weighed mass, and separately again from chromatographic purity — never on the label. Ask, and record the answer beside the batch number.

That the gap between printed and measured is real has actually been quantified. A 2024 market-surveillance study bought products from online sellers operating without prescription and subjected them to content analysis and visual label inspection. Measured content diverged from the labelled claim in both directions, and vendor claims of "at least 99%" purity were contradicted by substantially lower measured polypeptide concentrations. Scored against an adapted labelling checklist, the purchased items were non-compliant on roughly 59% to 64% of twenty-two criteria, with missing manufacturer expiry dates and absent track-and-trace among the recurring failures ^[8]. One study of one product category is not the whole supply chain, and the wider record of independent testing on grey-market vials is worth reading beside it — but it is direct evidence that label completeness is a measurable variable rather than an aesthetic one.

What the storage condition statement on a label means

The storage statement is not advice. It is the condition under which every time-dependent claim on the label — expiry, retest date, the stability data behind them — was generated and is asserted to hold. Change the condition and the dating claim is supported by nothing. ICH Q7 accordingly ties storage conditions to quality-critical information rather than treating them as a courtesy ^[1].

In the United States the vocabulary itself is defined compendially, and more narrowly than everyday usage suggests. USP General Chapter <659> fixes what the standard terms mean ^[7].

Two things follow. "Controlled" is doing real work: it implies a thermostatically maintained, monitored space assessed over time, not one reassuring reading taken once ^[7]. A container that spent four days in an unmonitored vehicle was not at controlled room temperature, whatever the label intended. And an undefined phrase is not a weaker version of a defined one — it is a different kind of object. "Store in a cool dry place" cannot be complied with, breached or audited, because it does not say anything. Where a research label gives a bare figure such as −20 °C instead, treat it as the supplier's assertion and ask what stability data sits behind it; specificity is not evidence.

Where the research use only statement comes from

The sentence "For Research Use Only. Not for use in diagnostic procedures." is not a supplier's turn of phrase. It is regulatory text, taken from 21 CFR 809.10(c)(2)(i), which requires that statement to be placed prominently on the labelling of an in vitro diagnostic product that is in the laboratory research phase of development and is not represented as an effective diagnostic product ^[3].

Which is worth being honest about: most research peptides are not in vitro diagnostic products, so that clause does not literally govern their labels. The statement travels as a borrowed convention — the clearest published wording for the category, adopted rather than imposed on this particular container. It marks a boundary. It is not a certification, a grade, or evidence of anything analytical.

The FDA has also been explicit that the statement is not a shield. Its 2013 guidance on the distribution of products labelled research use only or investigational use only rests on the point that a label statement does not by itself determine how a product is regulated: the agency weighs the totality of the circumstances, including how the product is marketed and to whom it is sold ^[4]. Read against a vial, that cuts one way. The statement describes what a supplier is permitted to say about the material, and any claim elsewhere in the same channel pointing somewhere else undermines it rather than coexisting with it.

Hazard labelling on a shipment into the US or Canada

Where a material is classified as hazardous, a separate regime governs the shipped container. The OSHA Hazard Communication Standard requires six elements: the product identifier used on the safety data sheet, a signal word, hazard statements, pictograms, precautionary statements, and the name, address and telephone number of the chemical manufacturer, importer or responsible party — with the signal word, hazard statements and pictograms located together in one field of view ^[5]. In Canada the supplier label under the Hazardous Products Regulations carries the product identifier, pictograms, a signal word, hazard statements and precautionary statements, in both English and French ^[6].

The honest qualification: many lyophilised research peptides are not classified as hazardous under either scheme, and where that holds no hazard label is required and its absence is not a defect. What is a defect is a supplier who cannot say which case applies, or cannot produce a safety data sheet on request. That question tests regulatory competence better than a pictogram does, because it cannot be answered by copying somebody else's artwork.

Reading a label as a set of commitments

One closing caveat, because the evidence here is thin. No published survey measures label-field completeness across research peptide suppliers specifically; the nearest data come from adjacent grey markets ^[8], and the standards quoted throughout were written for pharmaceutical manufacture and workplace chemical supply rather than for this trade ^[1][5][6]. What holds is narrow and still useful: the terms have public, defined meanings, and whether a supplier uses them precisely — or answers when asked which meaning was intended — is observable before anything is bought.